This indicates that the magnitude of differential expressions (BCC vs. non-lesional tissues) was more pronounced when there was a STR somatic mutation in APC (see Supplementary Table S14) or BRAF (see Supplementary Table S15), suggesting more marked dysregulation in these well-known gene pathways in BCC to be associated with such STR somatic mutations. The gene discussed is APC; the disease is skin basal cell carcinoma.